PGI23 Cost Effectiveness of Retreatment of Patients with Chronic Hepatitis C (Chc) Who Do Not Respond to Peginterferon Alpha and Ribavirin for 48 Weeks Vs. Peginterferon Alfa and Ribavirin for 72 Weeks
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.750
https://www.valueinhealthjournal.com/article/S1098-3015(12)00815-7/fulltext
Title :
PGI23 Cost Effectiveness of Retreatment of Patients with Chronic Hepatitis C (Chc) Who Do Not Respond to Peginterferon Alpha and Ribavirin for 48 Weeks Vs. Peginterferon Alfa and Ribavirin for 72 Weeks
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00815-7&doi=10.1016/j.jval.2012.03.750
First page :
A139
Section Title :
Gastrointestinal Disorders
Open access? :
No
Section Order :
228